Table 1 Demographic and structural data for 3 groups: ageing donors that had not suffered a fracture (Controls) and ageing fracture patients, both untreated (Fx-Untreated) and bisphosphonate-treated (Fx-BisTreated).
Donor group | Donor number | Sex | Age (years) | BV/TV | Treatment (years) |
|---|---|---|---|---|---|
Control | 1 | M | 84 | 0.30 | |
2 | M | 73 | 0.34 | ||
3 | F | 73 | 0.38 | ||
4 | F | 73 | 0.27 | ||
5 | F | 82 | 0.34 | ||
6 | F | 82 | 0.33 | ||
7 | F | 72 | 0.36 | ||
8 | F | 72 | 0.36 | ||
9 | M | 57 | 0.33 | ||
10 | M | 73 | 0.33 | ||
Fx-Untreated | 1 | F | 82 | 0.24 | |
2 | F | 76 | 0.28 | ||
3 | F | 82 | 0.24 | ||
4 | F | 81 | 0.25 | ||
5 | F | 75 | 0.25 | ||
6 | F | 74 | 0.22 | ||
7 | M | 94 | 0.24 | ||
8 | M | 79 | 0.26 | ||
9 | F | 90 | 0.31 | ||
10 | M | 78 | 0.26 | ||
Fx-BisTreated | 1 | F | 88 | 0.29 | 9 |
2 | F | 61 | 0.24 | 6 | |
3 | F | 79 | 0.26 | 5 | |
4 | F | 82 | 0.26 | 5 | |
5 | F | 84 | 0.37 | 5 | |
6 | F | 75 | 0.25 | 3 | |
7 | F | 82 | 0.42 | 2 | |
8 | M | 80 | 0.25 | 1 | |
9 | F | 68 | 0.23 | 1 | |
10 | F | 79 | 0.30 | 1 |
